Clinical trial
A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of…
NCT00282919 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00282919 |
|---|---|
| Title | A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria |
| Official title | A Phase 2, Open Label, Non-Comparative Trial Of Azithromycin 2000 mg Plus Chloroquine 600 Mg Base Daily For Three Days For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Falciparum Malaria |
| Intervention type | Drug |
| Interventions | Azithromycin plus chloroquine |
| Enrollment | 110 |
| Start date | Mar 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jan 27, 2006 |
| Last update posted | Jun 26, 2014 |
| Countries | Colombia, India |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: